ArcelorMittal announces US$1.0 billion three-year investment programme in Mexico
Sep 28, 2017 20:46 pm UTC| Business
28 September 2017 - ArcelorMittal ('the Company') today announces a major US$1 billion, three-year investment programme at its Mexican operations, which is focussed on building ArcelorMittal Mexico's downstream...
Sep 28, 2017 20:45 pm UTC| Business
SEATTLE, Sept. 28, 2017 -- Aptevo Therapeutics Inc. (Nasdaq:APVO), a biotechnology company focused on developing novel immuno-oncology and hematology therapeutics, today announced that it has amended the terms of a...
Aptevo Therapeutics Completes Sale of Hyperimmune Products for Up to $74.5 Million
Sep 28, 2017 20:35 pm UTC| Business
Sharpens Focus on Innovative ADAPTIR® Bispecific Antibody Platform and IXINITY® Commercial Asset Strengthens Cash Position to Advance RD and Commercial Strategy SEATTLE, Sept. 28, 2017 -- Aptevo Therapeutics Inc....
Sep 28, 2017 20:32 pm UTC| Business
BOSTON, Sept. 28, 2017 -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP), a biopharmaceutical company focusing on new immunotherapies, announces the appointment of David Mauney, M.D., as Executive Vice President and Chief...
Dime Community Bancshares Appoints Rosemarie Chen to its Board of Directors
Sep 28, 2017 20:30 pm UTC| Business
BROOKLYN, N.Y., Sept. 28, 2017 -- Dime Community Bancshares, Inc. (NASDAQ:DCOM) (the "Company" or "Dime"), the parent company of Dime Community Bank (the "bank"), announced the appointment of Rosemarie Chen to its Board...
Sep 28, 2017 20:30 pm UTC| Business
GARDNER, Mass., Sept. 28, 2017 -- Precision Optics Corporation, Inc. (OTCQB:PEYE) (the “Company”) today announced operating results on an unaudited basis for its fourth quarter and fiscal year ended June 30, 2017. ...
Sep 28, 2017 20:30 pm UTC| Business
WALTHAM, Mass., Sept. 28, 2017 -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, announced today the availability of a number of new support resources and services that address unmet...
Trump Says Ukraine Peace Deal ‘Closer,’ But Key Disputes Remain Unresolved